2011China Medical HeraldRequires access

Clinical evaluation of the use of Piperacillin/Tazobactam in lower respiratory tract infection

Xiaofeng Liu

Open publisher page 1 citations

Abstract

Objective: To investigate the clinical efficacy of Piperacillin/Tazobactam in treatment of lower respiratory tract infection.Methods: 80 cases of lower respiratory tract infection patients were divided into two groups with 40 cases in each group.Piperacillin/ Sulbactam was given to control group and Piperacillin/Tazobactam was given to treatment group.Results: The effective rates in the treatment group and control group were respectively 85.00% and 67.50%,and difference between the two groups was significant(P0.05).Piperacillin/Tazobactam group had the better clinical efficacy.Conclusion: Clinical efficacy of Piperacillin/Tazobactam used in lower respiratory tract infection patients is better.It has lower adverse reactions,and should be popularize in clinic.

About this research paper

What this paper is about

Objective: To investigate the clinical efficacy of Piperacillin/Tazobactam in treatment of lower respiratory tract infection.Methods: 80 cases of lower respiratory tract infection patients were divided into two groups with 40 cases in each group.Piperacillin/ Sulbactam was given to control group and Piperacillin/Tazobactam was given to treatment group.Results: The effective rates in the treatment group and control group were respectively 85.00% and 67.50%,and difference between the two groups was significant(P0.05).Piperacillin/Tazobactam group had the better clinical efficacy.Conclusion: Clinical efficacy of Piperacillin/Tazobactam used in lower respiratory tract infection patients is better.It has lower adverse reactions,and should be popularize in clinic.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To investigate the clinical efficacy of Piperacillin/Tazobactam in treatment of lower respiratory tract infection.Methods: 80 cases of lower respiratory tract infection patients were divided into two groups with 40 cases in each group.Piperacillin/ Sulbactam was given to control group and Piperacillin/Tazobactam was given to treatment group.Results: The effective rates in the treatment group and control group were respectively 85.00% and 67.50%,and difference between the two groups was significant(P0.05).Piperacillin/Tazobactam group had the better clinical efficacy.Conclusion: Clinical efficacy of Piperacillin/Tazobactam used in lower respiratory tract infection patients is better.It has lower adverse reactions,and should be popularize in clinic.

Key concepts: Medicine, Piperacillin/tazobactam, Piperacillin, Tazobactam, Respiratory tract, Respiratory tract infections, Clinical efficacy, Sulbactam

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical evaluation of the use of Piperacillin/Tazobactam in lower respiratory tract infection — Research Paper | ScholarLens